S&P 500   5,020.26 (-0.04%)
DOW   37,842.79 (+0.24%)
QQQ   423.90 (-0.46%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.94 (+0.17%)
T   16.28 (+0.99%)
F   12.04 (+0.00%)
MU   112.27 (-3.49%)
GE   153.93 (-1.12%)
CGC   8.01 (+23.42%)
DIS   112.88 (-0.05%)
AMC   2.92 (-2.01%)
PFE   25.37 (-0.20%)
PYPL   62.25 (-1.60%)
XOM   118.52 (-0.09%)
S&P 500   5,020.26 (-0.04%)
DOW   37,842.79 (+0.24%)
QQQ   423.90 (-0.46%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.94 (+0.17%)
T   16.28 (+0.99%)
F   12.04 (+0.00%)
MU   112.27 (-3.49%)
GE   153.93 (-1.12%)
CGC   8.01 (+23.42%)
DIS   112.88 (-0.05%)
AMC   2.92 (-2.01%)
PFE   25.37 (-0.20%)
PYPL   62.25 (-1.60%)
XOM   118.52 (-0.09%)
S&P 500   5,020.26 (-0.04%)
DOW   37,842.79 (+0.24%)
QQQ   423.90 (-0.46%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.94 (+0.17%)
T   16.28 (+0.99%)
F   12.04 (+0.00%)
MU   112.27 (-3.49%)
GE   153.93 (-1.12%)
CGC   8.01 (+23.42%)
DIS   112.88 (-0.05%)
AMC   2.92 (-2.01%)
PFE   25.37 (-0.20%)
PYPL   62.25 (-1.60%)
XOM   118.52 (-0.09%)
S&P 500   5,020.26 (-0.04%)
DOW   37,842.79 (+0.24%)
QQQ   423.90 (-0.46%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.94 (+0.17%)
T   16.28 (+0.99%)
F   12.04 (+0.00%)
MU   112.27 (-3.49%)
GE   153.93 (-1.12%)
CGC   8.01 (+23.42%)
DIS   112.88 (-0.05%)
AMC   2.92 (-2.01%)
PFE   25.37 (-0.20%)
PYPL   62.25 (-1.60%)
XOM   118.52 (-0.09%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CryoLife, Inc. stock logo
CRY
CryoLife
$19.05
$16.95
$32.34
$703.22M1.53198,221 shs7,792 shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$29.75
-0.5%
$28.12
$23.10
$53.50
$707.75M1.16185,642 shs41,390 shs
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
$5.22
-0.6%
$6.56
$4.38
$8.45
$399.38M0.15897,167 shs403,121 shs
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$14.20
+0.3%
$15.45
$9.69
$26.11
$337.39M1.19289,389 shs70,746 shs
Vapotherm, Inc. stock logo
VAPO
Vapotherm
$1.36
$1.22
$0.75
$7.44
$8.43M-1.113,980 shs435 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CryoLife, Inc. stock logo
CRY
CryoLife
0.00%0.00%0.00%0.00%0.00%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-0.93%-5.89%+19.60%+5.47%-38.08%
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
+0.57%-9.33%-22.79%-34.86%-21.29%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
-1.53%-5.85%-10.58%+2.39%-20.00%
Vapotherm, Inc. stock logo
VAPO
Vapotherm
0.00%-4.23%+0.74%+33.01%-67.41%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CryoLife, Inc. stock logo
CRY
CryoLife
N/AN/AN/AN/AN/AN/AN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
4.0055 of 5 stars
3.41.00.03.92.54.20.6
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
4.1064 of 5 stars
2.25.00.04.22.41.71.9
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
4.4981 of 5 stars
3.55.00.00.03.92.53.1
Vapotherm, Inc. stock logo
VAPO
Vapotherm
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CryoLife, Inc. stock logo
CRY
CryoLife
N/AN/AN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
2.75
Moderate Buy$42.5042.86% Upside
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
2.33
Hold$6.3822.13% Upside
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
3.00
Buy$30.00111.27% Upside
Vapotherm, Inc. stock logo
VAPO
Vapotherm
N/AN/AN/AN/A

Current Analyst Ratings

Latest KIDS, TCMD, OSUR, CRY, and VAPO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/10/2024
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$37.00
4/4/2024
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetIn-Line ➝ In-Line$7.00 ➝ $6.50
3/7/2024
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$50.00
1/25/2024
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$39.00 ➝ $31.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CryoLife, Inc. stock logo
CRY
CryoLife
$253.23M0.00N/A23.30$8.46 per share0.00
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$148.73M4.76N/AN/A$16.14 per share1.84
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
$405.47M0.98$1.34 per share3.89$5.86 per share0.89
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$274.42M1.23$1.52 per share9.37$8.24 per share1.72
Vapotherm, Inc. stock logo
VAPO
Vapotherm
$68.67M0.12N/AN/A($9.01) per share-0.15

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CryoLife, Inc. stock logo
CRY
CryoLife
-$16.68M$0.03596.200.00N/A0.63%4.24%1.63%N/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$20.97M-$0.92N/AN/AN/A-14.10%-5.03%-4.37%5/6/2024 (Estimated)
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
$53.65M$0.727.25N/AN/A13.23%14.50%12.69%5/8/2024 (Estimated)
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$28.51M$1.2011.8316.14N/A10.39%17.08%10.50%5/6/2024 (Confirmed)
Vapotherm, Inc. stock logo
VAPO
Vapotherm
-$58.19M-$9.90N/AN/A-84.74%N/A-65.84%5/1/2024 (Estimated)

Latest KIDS, TCMD, OSUR, CRY, and VAPO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2024N/A
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
-$0.11N/A+$0.11N/AN/AN/A  
3/6/2024Q4 2023
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.28-$0.23+$0.05-$0.17$37.59 million$37.61 million
2/27/2024Q4 2023
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
$0.13$0.22+$0.09$0.17$74.13 million$75.88 million    
2/22/2024Q4 2023
Vapotherm, Inc. stock logo
VAPO
Vapotherm
N/A-$1.60-$1.60-$1.60N/A$19.73 million
2/20/202412/31/2023
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$0.13$0.38+$0.25$0.41$78.85 million$77.65 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CryoLife, Inc. stock logo
CRY
CryoLife
N/AN/AN/AN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
N/AN/AN/AN/AN/A
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
N/AN/AN/AN/AN/A
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
N/AN/AN/AN/AN/A
Vapotherm, Inc. stock logo
VAPO
Vapotherm
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CryoLife, Inc. stock logo
CRY
CryoLife
0.99
4.21
2.93
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
0.03
5.44
2.90
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
N/A
9.77
8.57
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
0.14
3.54
2.99
Vapotherm, Inc. stock logo
VAPO
Vapotherm
N/A
2.43
1.23

Ownership

Institutional Ownership

CompanyInstitutional Ownership
CryoLife, Inc. stock logo
CRY
CryoLife
81.57%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
69.05%
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
93.50%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
83.43%
Vapotherm, Inc. stock logo
VAPO
Vapotherm
43.08%

Insider Ownership

CompanyInsider Ownership
CryoLife, Inc. stock logo
CRY
CryoLife
4.50%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
32.60%
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
3.40%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
0.96%
Vapotherm, Inc. stock logo
VAPO
Vapotherm
15.80%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
CryoLife, Inc. stock logo
CRY
CryoLife
1,20039.33 million37.56 millionOptionable
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
24723.79 million16.03 millionOptionable
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
63876.51 million73.91 millionOptionable
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
99223.76 million23.53 millionOptionable
Vapotherm, Inc. stock logo
VAPO
Vapotherm
1826.20 million5.22 millionOptionable

KIDS, TCMD, OSUR, CRY, and VAPO Headlines

SourceHeadline
Onymos Powers Connected Cloud App for Global Medical Technology Company, VapothermOnymos Powers Connected Cloud App for Global Medical Technology Company, Vapotherm
dbta.com - March 25 at 5:37 PM
Vapotherm to debut home ventilator to improve patient careVapotherm to debut home ventilator to improve patient care
msn.com - March 20 at 7:36 PM
Onymos and Vapotherm Announce Partnership to Create an End-to-End Internet of Medical Things Solution (IoMT)Onymos and Vapotherm Announce Partnership to Create an End-to-End Internet of Medical Things Solution (IoMT)
finance.yahoo.com - March 20 at 7:36 PM
Vapotherm to Unveil Access365 Home Ventilation Solution at MEDTRADEVapotherm to Unveil Access365 Home Ventilation Solution at MEDTRADE
finance.yahoo.com - March 15 at 10:23 AM
Dr. David Yamane was awarded the Star Research Award at the 2024 Critical Care Congress for the presentation of the HYPERACT Study - a randomized controlled trial demonstrating Vapotherms High Velocity Therapy effectively treats moderate-severe acute exacerbations of COPD, while improving patient comfortDr. David Yamane was awarded the Star Research Award at the 2024 Critical Care Congress for the presentation of the HYPERACT Study - a randomized controlled trial demonstrating Vapotherm's High Velocity Therapy effectively treats moderate-severe acute exacerbations of COPD, while improving patient comfort
prnewswire.com - March 6 at 6:45 AM
Vapotherms HVT 2.0 System Overcomes Regulatory Hurdles for Entry into South Americas Largest Health Care MarketVapotherm's HVT 2.0 System Overcomes Regulatory Hurdles for Entry into South America's Largest Health Care Market
prnewswire.com - February 29 at 6:45 AM
Vapotherm, Inc.: Vapotherm Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsVapotherm, Inc.: Vapotherm Reports Fourth Quarter and Fiscal Year 2023 Financial Results
finanznachrichten.de - February 23 at 7:30 AM
Vapotherm: Q4 Earnings SnapshotVapotherm: Q4 Earnings Snapshot
chron.com - February 22 at 9:28 PM
Vapotherm Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsVapotherm Reports Fourth Quarter and Fiscal Year 2023 Financial Results
prnewswire.com - February 22 at 4:10 PM
Innovations Shaping The Future Of Standalone High Flow Oxygen Therapy Devices Market DynamicsInnovations Shaping The Future Of Standalone High Flow Oxygen Therapy Devices Market Dynamics
opprairie.com - February 12 at 10:06 AM
Vapotherm: Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Financial Statements And ExhibitsVapotherm: Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Financial Statements And Exhibits
cbonds.com - December 17 at 8:45 AM
OTC Markets Group Welcomes Vapotherm, Inc. to OTCQXOTC Markets Group Welcomes Vapotherm, Inc. to OTCQX
financialpost.com - December 15 at 7:08 AM
NYSE to Commence Delisting Proceedings Against Vapotherm, Inc. (VAPO)NYSE to Commence Delisting Proceedings Against Vapotherm, Inc. (VAPO)
finance.yahoo.com - December 14 at 8:20 PM
Vapotherm Shares Suspended on NYSE, Company Previously Announced Voluntary Delisting PlanVapotherm Shares Suspended on NYSE, Company Previously Announced Voluntary Delisting Plan
marketwatch.com - December 14 at 8:20 PM
Vapotherm Shares Decline 22% on Voluntary Delisting Grom NYSEVapotherm Shares Decline 22% on Voluntary Delisting Grom NYSE
marketwatch.com - December 11 at 1:11 PM
Vapotherm slips on announcing voluntary delisting from NYSE to OTCQX MarketplaceVapotherm slips on announcing voluntary delisting from NYSE to OTCQX Marketplace
msn.com - December 11 at 8:11 AM
Vapotherm Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock Application Pending to Transfer Shares to OTCQXVapotherm Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock Application Pending to Transfer Shares to OTCQX
finance.yahoo.com - December 11 at 8:11 AM
Vapotherm Educates over 8,000 Clinicians in Respiratory Care MonthVapotherm Educates over 8,000 Clinicians in Respiratory Care Month
finance.yahoo.com - November 28 at 8:21 PM
Vapotherm, Inc. (NYSE:VAPO) Q3 2023 Earnings Call TranscriptVapotherm, Inc. (NYSE:VAPO) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 10 at 2:28 PM
Vapotherm GAAP EPS of -$2.38 misses by $0.18, revenue of $15.2M misses by $1.52MVapotherm GAAP EPS of -$2.38 misses by $0.18, revenue of $15.2M misses by $1.52M
msn.com - November 8 at 7:38 PM
Vapotherm Reports Third Quarter 2023 Financial ResultsVapotherm Reports Third Quarter 2023 Financial Results
finance.yahoo.com - November 8 at 7:38 PM
Vapotherm, Inc. (VAPO) stock price, news, quote & history – Yahoo FinanceVapotherm, Inc. (VAPO) stock price, news, quote & history – Yahoo Finance
uk.finance.yahoo.com - November 8 at 9:36 AM
Earnings Outlook For VapothermEarnings Outlook For Vapotherm
benzinga.com - November 7 at 6:13 PM
Vapotherm To Report Third Quarter 2023 Financial ResultsVapotherm To Report Third Quarter 2023 Financial Results
finance.yahoo.com - November 1 at 8:30 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

CryoLife logo

CryoLife

NYSE:CRY
CryoLife, Inc. engages in the manufacture, process and distribution of medical devices and implantable human tissues. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes revenues from sales of BioGlue products, aortic stents and stent grafts, On-X products, CardioGenesis cardiac laser therapy, PerClot, and PhotoFix. The Preservation Services segment focuses on revenues from preservation of cardiac and vascular implantable human tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.
OrthoPediatrics logo

OrthoPediatrics

NASDAQ:KIDS
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
OraSure Technologies logo

OraSure Technologies

NASDAQ:OSUR
OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Additionally, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.
Tactile Systems Technology logo

Tactile Systems Technology

NASDAQ:TCMD
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Vapotherm logo

Vapotherm

NYSE:VAPO
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.